medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2014, Number 3

<< Back Next >>

Rev Mex Patol Clin Med Lab 2014; 61 (3)

Epidemiological behavior of thyroid cancer in patients with survival of 20 years and more

Lasserra SÓ, Álvarez MI, Martínez HB

Language: Spanish
References: 40
Page: 175-184
PDF size: 159.77 Kb.


ABSTRACT

Objective: To characterize the epidemiological, diagnostic, and therapeutic behavior of patients with thyroid cancer (TC), with a survival greater than or equal to 20 years.
Method: A retrospective and cross-sectional descriptive study was conducted in the Provincial Teaching Oncological Hospital «María Curie», Camagüey. The sample included 85 patients with diagnosis of TC who fulfilled the inclusion criteria. The epidemiological behavior of these patients was determined to the 20 years of their treatment.
Results: The female sex predominated with 95.29%. The papillary carcinoma was the histological variety more detected. The majority were diagnosed at stage I, thyroidectomy was used as surgical technique and as adjuvant therapy the Iodine-131 and hormonotherapy in accordance. The presence of metastases was not predominant at the time of diagnosis and patient survival was about 25 to 29 years on average.
Conclusions: Although thyroid cancer is a current health problem, achieve a survival of 25 to 29 years on average, when there is diagnostic specificity and therapeutic effectiveness.


REFERENCES

  1. American Cancer Society. Cancer Facts and Figures 2009. Atlanta, Ga: American Cancer Society [Internet]; 2009 [Citado 26 de mayo 2012]. Available in: http://www.cancer.org/downloads/STT/500809web.pdf

  2. Lope Carvajal V, Pollán Santamaría M. Epidemiología del cáncer diferenciado de tiroides. Endocrinol Nutr. 2005; 52 (Supl 1): 2-10.

  3. Carling T, Udelsman R. Thyroid tumors. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 7th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005: pp. 1502-1519.

  4. Schlumberger MJ, Filetti S, Hay ID. Bocio no tóxico y neoplasia de tiroides. Williams: Tratado de Endocrinología. 10a ed. Madrid: Elsevier; 2004: pp. 509-531.

  5. Ferlay J, Bray F, Sankila R, Parkin DM. EUCAN: cancer incidence, mortality and prevalence in the European Union 1998, version 5.0.IARC.

  6. American Cancer Society. Cancer facts and figures [Internet]. Atalta, Ga: American Cancer Society. 2012 [access 14 June, 2012]. Available in: http://www.cancer.org/acs/groups/content/@epidemiologysurverlance/documents/document/acspc-031941.pdf

  7. Navarro Despaigne D. Epidemiología de las enfermedades del tiroides en Cuba. Rev Cubana Endocrinol [revista en la Internet]. 2004 [citado 09 de agosto 2012]; 15 (1): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532004000100004&lng=es

  8. Tronko MD, Howe GR, Bogdanova TI et al. A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening. J Natl Cancer Inst. 2006 [access 2012, Ago 09]; 98 (13): 897-903. Available in: http://www.ncbi.nlm.nih.gov/pubmed/16818853?dopt=Abstract

  9. Cardis E, Kesminiene A, Ivanov V et al. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst. 2005; 97 (10): 724-732. Available in: http://www.ncbi.nlm.nih.gov/pubmed/15900042?dopt=Abstract

  10. Voutilainen PE, Multanen MM, Leppäniemi AK et al. Prognosis after lymph node recurrence in papillary thyroid carcinoma depends on age. Thyroid. 2001; 11 (10): 953-957. Available in: http://www.ncbi.nlm.nih.gov/pubmed/11716043?dopt

  11. Thyroid. In: American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002: pp. 77-87.

  12. Haigh PI, Urbach DR. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart. Surgery. 2005; 138 (6): 1152-1157. Available in: http://www.ncbi.nlm.nih.gov/pubmed/16360403?dopt=Abstract

  13. Sherman S. Thyroid carcinoma. Lancet. 2003; 1361 (9356): 501-511.

  14. González-Fernández R, Infante-Amorós A, López-Soto MV, De Dios Vidal JM. Protocolo de diagnóstico y tratamiento del cáncer tiroideo. Rev Cubana Cir [Internet]. 2004 [acceso 9 de agosto de 2012]; 43 (2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-74932004000200001&lng=es

  15. Gupta-Abramson V, Troxel AB, Nellore A et al. Phase II trial of sorafenib in advanced thyroid cancer. J Clin Oncol. 2008; 26 (29): 4714-9. Epub 2008 Jun 9. Available in: http://www.ncbi.nlm.nih.gov/pubmed/18541894?dopt=Abstract.

  16. Sharma PK, Johns IMM. Thyroid cancer. Medicine.com: Head and Neck Oncology [actualizada en 2007; acceso 28 de marzo de 2008].

  17. Guerra MJ. Carcinoma anaplásico del tiroides. Consideraciones de actualidad. Rev Cubana Cir. 2001; 40 (2): 99-105.

  18. Cassola SJ. Carcinoma folicular del tiroides ¿hasta qué punto un conflicto? Rev Cubana Oncol. 2000; 2 (16): 128-34.

  19. Iribarren C, Haselkorn T, Tekawa IS et al. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer. 2001; 93 (5): 745-750. Available in: http://www.ncbi.nlm.nih.gov/pubmed/11477590?dopt=Abstract.

  20. De Crevoisier R, Baudin E, Bachelot A et al. Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. Int J Radiat Oncol Biol Phys. 2004; 60 (4): 1137-1143. Available in: http://www.ncbi.nlm.nih.gov/pubmed/15519785?dopt=Abstract.

  21. Gómez KA, Gómez VM, Fernández NF, Roux G. Incidencia del cáncer de tiroides en pacientes tiroidectomizados. Hospital “Dr. José R. Vidal” de la ciudad de Corrientes. Rev de Posgrado VI Cátedra de Medicina. 2007; 175: 1-3.

  22. Blanco Carrera C, Peláez Torres N, García-Díaz JD, Maqueda Villaizan E, Sanz JM, Álvarez Hernández J. Estudio epidemiológico y clinicopatológico del cáncer de tiroides en la zona este de Madrid. Rev Clin Esp. 2005; 205 (7): 307-310.

  23. Flores-Ortega A, Rivera-López E, Guillén-González MA, Vergara-López A. Cáncer de tiroides: Revisión de casos del Centro Médico Nacional “20 de Noviembre”. Rev Endocrinol Nutr. 2010; 18 (1): 11-17.

  24. De la Guardia GE, Quintana Proenza A, Quintana Marrero JJ, Sánchez Rojas T, Reyes Balseiro ES, de la Guardia Milla E. Panorámica diagnóstica y terapéutica del cáncer de tiroides en Camagüey. Rev Cubana Cir [Internet]. 2001 [acceso 2012, Nov 28]; 40 (4): 263-267. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-74932001000400003&lng=es

  25. Valenciaga Rodríguez JL, Galán Álvarez Y, Turcios Tristá SE, Piña Rivera Y, Navarro Despaigne D, Barroso López O. Cáncer de tiroides en Cuba: estudio de 14 años. Rev Cuba Endocrinol. 2005; 16 (3).

  26. Memom A, Darif M, Al-Saleh K, Suresh A. Epidemiology of reproductive and humoral factors of thyroid cancer: evidence from a case-control study in the Middle East. Int J Cancer. 2001; 97: 82-89.

  27. Hooft L, Hoekstra O, Boers M, Van Tulder M, Van Diest P, Lips P. Practice, efficacy and cost of thyroid nodule evaluation: a retrospective study in a Dutch university hospital. Thyroid. 2004; 14: 283-293.

  28. Falvo L, Catania A, Surrenti S, D Andrea V, Berni A, De Steffano M et al. Prognostic significance of the age factors in the thyroid cancer: statistical analyses. J Surg Oncol. 2004; 88: 217-222.

  29. Schlumberger MJ, Filetti S, Hay ID. Nontoxic goiter and thyroid neoplasis. In: Reed L, Kronenberg H, Melmed S, Polonsky K. Williams textbook of endocrinology. Philadelphia: 2002. p. 457-484.

  30. Cardoso A, Pianovski M, Franca S. Thyroid cancer in childhood and adolescence: report of 15 cases. Arq Bras Endocrinol Metab. 2004; 48: 835-841.

  31. Piraino NP, Sepúlveda NA, Lillo GR, Pineda BP, Liberman GC. Thyroid cancer: Report of 85 cases. Rev Med Chile [Internet]. 2000 [acceso 09 de agosto de 2012]; 128 (4): 405-410. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000400007&lng=es. doi: 10.4067/S0034-98872000000400007.

  32. Lucena Olavarrieta JR. Carcinoma del tiroides. Resultado del tratamiento quirúrgico. Rev Venez Oncol. 2005; 17 (3): 129-134.

  33. Roubicek Martin IG. Cáncer de tiroides: experiencia hospitalaria en 20 años. Medicina Buenos Aires [Internet]. 1996 [acceso 05 de diciembre de 2012]; 56 (2). Disponible en: http://www.scielo.org.ar/scielo.php?script.

  34. Famakinwa OM, Roman SA, Wang TS, Sosa JA. ATA practice guidelines for the treatment of differentiated thyroid cancer: were they followed in the United States? Am J Surg. 2010; 199: 189-198.

  35. Gómez-Sáez JM. ¿Está de acuerdo nuestra conducta ante el nódulo tiroideo y cáncer diferenciado de tiroides con la guía norteamericana y el consenso europeo? Endocrinol Nutr. 2010; 57: 357-363.

  36. González CC, Yaniskowski ML, Wyse EP, Giovannini AA, López MB, Wior ME. Thyroid carcinoma: A descriptive retrospective study. Medicina (Buenos Aires) [Internet]. 2006 [acceso 09 de agosto 2012]; 66 (6): 526-532. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802006000600005&lng=es.

  37. Louise D, Welch G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295: 2164-2167.

  38. UK Thyroid Cancer incidence statistics. Canadian Cancer Statistics 2006 [Internet]. Disponible en: http://info.cancerresearchuk.org/cancerstats/types/thyroid/

  39. Pacini F, De Groot LJ. The thyroid and its diseases. Chapter 18: thyroid cancer. Abbott; 2006.

  40. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab. 2004; 89: 3713-3720.




2020     |     www.medigraphic.com